Home/Filings/4/0001485003-21-000158
4//SEC Filing

Honig Peter 4

Accession 0001485003-21-000158

CIK 0001485003other

Filed

Jul 20, 8:00 PM ET

Accepted

Jul 21, 5:37 PM ET

Size

5.8 KB

Accession

0001485003-21-000158

Insider Transaction Report

Form 4
Period: 2021-07-20
Honig Peter
Director
Transactions
  • Award

    Stock Option

    2021-07-20+185,000185,000 total
    Exercise: $3.86Exp: 2031-07-20Common Stock (185,000 underlying)
Footnotes (1)
  • [F1]The option was granted on July 20, 2021 and vests monthly in equal amounts over a three-year period following the grant date. Based on market analysis by Radford of public, pre-commercial biopharmaceutical companies with less than 200 employees and market values between $250 million and $1 billion, the compensation committee of Sesen Bio, Inc. (the "Company") recommended to the Company's board of directors, and the board of directors approved, the amount of the initial grant to the reporting person in connection with the reporting person's appointment as a non-employee director.

Issuer

Sesen Bio, Inc.

CIK 0001485003

Entity typeother

Related Parties

1
  • filerCIK 0001484780

Filing Metadata

Form type
4
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 5:37 PM ET
Size
5.8 KB